Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long‐term extension data from a Phase 3 study

BACKGROUND: Ferric maltol was effective and well‐tolerated in iron deficiency anaemia patients with inflammatory bowel disease during a 12‐week placebo‐controlled trial. AIM: To perform a Phase 3 extension study evaluating long‐term efficacy and safety with ferric maltol in inflammatory bowel diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, C., Ahmad, T., Tulassay, Z., Baumgart, D. C., Bokemeyer, B., Howaldt, S., Stallmach, A., Büning, C., Baumgart, Daniel C., Bokemeyer, Bernd, Büning, Carsten, Helwig, Ulf, Howaldt, Stefanie, Hüppe, Dietrich, Krummenerl, Annette, Krummenerl, Thomas, Kühbacher, Tanja, Landry, Wilfried, Lügering, Andreas, Maaser, Christian, Mroß, Michael, Seidler, Ursula, Stallmach, Andreas, Stein, Jürgen, Teich, Niels, Horvath, Gabor, Kristóf, Tünde, László, András, Molnár, Tamás, Salamon, Ágnes, Tulassay, Zsolt, Vincze, Áron, Krayenbuehl, Pierre, Ahmad, Tariq, Beales, Ian, Brookes, Matthew, Campbell, Simon, Cummings, Fraser, Ede, Ronald, Elphick, David, Ireland, Alan, Kejariwal, Deepak, Li, Andy, Mansfield, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Iron Deficiency Anaemia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089582/
https://www.ncbi.nlm.nih.gov/pubmed/27237709
http://dx.doi.org/10.1111/apt.13665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089582/
https://www.ncbi.nlm.nih.gov/pubmed/27237709
http://dx.doi.org/10.1111/apt.13665

Ejemplares similares